Feasibility of autologous plasma gel for tonsil-derived stem cell therapeutics in hypoparathyroidism

Hypoparathyroidism is a deficiency of the parathyroid hormone (PTH) in the body. We previously reported the possibility of treating it using tonsil-derived mesenchymal stem cells (TMSCs) differentiated into PTH-releasing cells. The purpose of this study was to evaluate the feasibility of using autol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Soo Yeon, Kim, Ha Yeong, Oh, Hyun Ju, Choi, Euno, Cho, Min Sun, Kim, Han Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085304/
https://www.ncbi.nlm.nih.gov/pubmed/30093637
http://dx.doi.org/10.1038/s41598-018-30454-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085304/
https://www.ncbi.nlm.nih.gov/pubmed/30093637
http://dx.doi.org/10.1038/s41598-018-30454-1

Ejemplares similares